drugset / Trial / NCT07070934
CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective study comparing anti-BCMA CAR-T to autologous hematopoietic stem cell transplantation alone in the treatment of newly diagnosed multiple myeloma patients.
Timeline
- Start
- 2025-07-15
- Primary completion
- 2026-07-15
- Completion
- 2028-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CAR-T | Cell therapy | 2 cells/kg | — |